ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,484Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 890

$781K Total Retail Price of All Prescriptions

Rank: 106 out of 890

545 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 545 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

17% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,877 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 808 756 1 2
SIMVASTATIN 533 452 2 5
METFORMIN HCL 470 375 3 6
HYDROCODONE-ACETAMINOPHEN 413 276 S3 4 3
HYDROCHLOROTHIAZIDE 402 347 5 9
LISINOPRIL 390 292 6 4
OMEPRAZOLE 350 303 7 8
AMLODIPINE BESYLATE 309 253 8 1
CITALOPRAM HBR 264 236 9 20
GABAPENTIN 244 201 10 12
FUROSEMIDE 240 205 11 7
ZOLPIDEM TARTRATE 235 143 12 19
GLIMEPIRIDE 234 230 13 27
PRAVASTATIN SODIUM 213 156 14 10
MELOXICAM 201 186 15 18
METOPROLOL TARTRATE 195 191 16 15
WARFARIN SODIUM 178 163 17 24
POTASSIUM CHLORIDE 167 140 18 11
NEXIUM 162 116 19 14
ATENOLOL 154 135 20 23
TRAMADOL HCL 153 124 21 16
BISOPROLOL FUMARATE 153 131 21 163
DIOVAN 151 121 23 33
ALLOPURINOL 146 139 24 31
AZITHROMYCIN 144 113 25 37
CLOPIDOGREL 141 118 26 28
FENOFIBRATE 128 122 27 74
ATORVASTATIN CALCIUM 127 116 28 13
SYNTHROID 120 111 29 53
METOPROLOL SUCCINATE 116 93 30 17
FLUTICASONE PROPIONATE 114 94 31 39
CRESTOR 111 111 32 25
SERTRALINE HCL 106 78 33 26
PLAVIX 105 98 34 42
LOVASTATIN 104 93 35 46
TAMSULOSIN HCL 103 81 36 32
CYMBALTA 100 73 37 45
PANTOPRAZOLE SODIUM 100 87 37 34
TRAZODONE HCL 99 66 39 40
PREMARIN 98 82 R 40 105
LOSARTAN POTASSIUM 96 83 41 29
GLIPIZIDE 94 85 42 62
CARVEDILOL 92 81 43 22
CARISOPRODOL 92 38 R 43 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 71 43 21
CELEBREX 91 81 46 91
CLONIDINE HCL 90 54 47 35
ACTOS 84 76 48 88
ESTRADIOL 82 74 R 49 118
PAROXETINE HCL 81 72 50 68
ZETIA 80 69 51 81
DONEPEZIL HCL 80 80 51 30
LYRICA 79 53 53 71
AMITRIPTYLINE HCL 78 74 R 54 43
TRIAMTERENE-HCTZ 75 70 55 61
FLUOXETINE HCL 75 44 55 63
ESCITALOPRAM OXALATE 73 64 57 51
TRICOR 72 58 58 98
LOSARTAN-HYDROCHLOROTHIAZIDE 72 60 58 57
ENALAPRIL MALEATE 71 71 60 56
ROPINIROLE HCL 71 61 60 93
NAMENDA 71 71 60 36
CYCLOBENZAPRINE HCL 69 32 R 63 64
FLUCONAZOLE 66 55 64 155
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 46 65 76
BENAZEPRIL HCL 63 51 66 44
LANTUS 63 60 66 50
GEMFIBROZIL 63 60 66 103
DILTIAZEM 24HR CD 60 52 69 156
LEVOFLOXACIN 59 50 70 107
AMLODIPINE BESYLATE-BENAZEPRIL 59 54 70 41
INSULIN SYRINGE 55 55 72 99
VERAPAMIL ER 53 53 73 87
DETROL LA 52 51 74 164
CIPROFLOXACIN HCL 51 43 75 58
JANUVIA 51 51 75 59
PRAMIPEXOLE DIHYDROCHLORIDE 50 50 77 175
METHYLPREDNISOLONE 50 39 77 109
LOVAZA 50 27 77 120
RAMIPRIL 50 38 77 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.